Is NICE Ltd. (NICE) One of the Best Prison and Law Enforcement Stocks to Buy According to Analysts?
We recently published a list of . In this article, we are going to take a look at where NICE Ltd. (NASDAQ:NICE) stands against other best prison and law enforcement stocks to buy.
According to the United Nations Office on Drugs and Crime, an estimated 11.7 million people were detained in prisons across the globe at the end of 2019. This translates to the population of entire countries such as Belgium, Tunisia, Bolivia, or Burundi. The number of people detained in prisons has increased by over 25% since 2000. While a majority of the people imprisoned over the last two decades are men, at around 93%, the number of women in prisons is rising at a faster pace, undergoing a 33% growth as compared to a 25% rise in men.
These growing numbers are being reflected in other trends in the industry as well. According to Grand View Research, the US law enforcement PPE (personal protective equipment) industry had a market size of $839.4 million in 2021. It is expected to grow at a compound annual growth rate of 5.0% between 2022 and 2030. Since awareness regarding officer safety in riot control and tactical situations is gaining ground, it is positively impacting growth in this industry. Demand for law enforcement PPE, including face shields, protective clothing, respirator masks, goggles, and surgical masks, especially surged during the COVID-19 pandemic.
READ ALSO: and .
Various other trends are also materializing in the law enforcement industry. At the end of 2024, CNBC reported that police departments across the United States are beginning to use AI to write police reports. Various companies are developing AI tools to aid police departments in easing the burden of administrative tasks, with law enforcement focusing on slashing budget pressures and crime rates while retaining and recruiting staff.
However, legal experts are simultaneously raising red flags over the increasing use of AI in police work, citing concerns such as transparency, accuracy, and potential bias. These challenges can affect the future of AI in law enforcement and policing. A significant part of the impact depends upon the extent to which such tools are used and how they are adopted in the sector. CNBC reported that Utah State Senator Stephanie Pitcher, a defense attorney with Parker & McConkie, said the following about the situation:
'For all of the potential issues that AI technology creates in terms of admissibility of evidence, in terms of being completely transparent, in terms of trying to mitigate the biases that can be introduced into the system, I just don't know that it's worth it.'
We sifted through stock screeners, financial media reports, and ETFs to compile a list of 20 prison and law enforcement stocks and chose the top 11 with the highest analyst upside potential as of April 25, 2025. We also included the number of hedge fund holders for each stock as of fiscal Q4 2024, sourcing the hedge fund sentiment data from Insider Monkey's database. The list is ordered in ascending order of analyst upside potential.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points ().
A data scientist sitting in front of a monitor to review the performance of AI-driven digital business solutions.
Analyst Upside: 29.02%
Number of Hedge Fund Holders: 28
NICE Ltd. (NASDAQ:NICE) provides enterprise software solutions and services. Its operations are divided into two segments: Financial Crime and Compliance Solutions, and Customer Engagement. The Financial Crime and Compliance Solutions segment employs embedded AI solutions to identify risks, prevent fraud and money laundering, and ensure real-time financial market compliance. The Customer Engagement segment offers suites such as compliance and risk, operational efficiency, and more. The company ranks 11th on our list of the 11 best prison and law enforcement stocks to buy according to analysts and has various applications in the industry. This includes its Evidencentral, which is a digital evidence management platform specifically designed for public safety, law enforcement, and criminal justice agencies.
The company is operating soundly. Its cloud revenue for fiscal Q4 2024 rose 24% to $534 million, the highest cloud growth on the largest cloud revenue base in the industry. Quarter-to-quarter cloud growth between fiscal Q3 2024 and fiscal Q4 2024 also accelerated to 6.8%. The notable cloud revenue growth drove a healthy year-over-year increase in total revenue for the company, reflecting its strength at the high end of the market. NICE Ltd. (NASDAQ:NICE) also reached a milestone of over 400 enterprise cloud customers with over $1 million in ARR.
On March 25, NICE Ltd. (NASDAQ:NICE) announced a collaboration with Deloitte Digital with the aim of transforming customer service by offering service automation and end-to-end AI. The collaboration would help make customer service a distinct feature of organizations supported by AI-powered enhancements. On April 16, Morgan Stanley analyst Meta Marshall maintained a Buy rating on NICE Ltd. (NASDAQ:NICE) and set a price target of $202.00.
Overall, NICE ranks 11th on our list of the best prison and law enforcement stocks to buy. While we acknowledge the potential for NICE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than NICE but trades at less than 5 times its earnings, check out our report about this cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
37 minutes ago
- Miami Herald
Warren Buffett's Berkshire Hathaway expects housing market price changes soon
Homebuyers have faced a turbulent housing market over the past few years. Rising home prices and elevated mortgage rates have forced many Americans to reconsider or postpone homeownership until conditions become more affordable. In 2020 and 2021, home prices skyrocketed as moving patterns shifted from cities and homebuyers began to take advantage of record-low mortgage rates below 3%. After the initial Covid-era housing boom, surging inflation in 2022 exacerbated housing prices that were already on the rise. Don't miss the move: SIGN UP for TheStreet's FREE daily newsletter As mortgage rates inch back toward 7%, homebuyers have tempered their expectations for a strong 2025 housing market rebound, but rising home inventory may be enough to lure them back to the market. Though the outlook for the second half of the year is uncertain, many experts believe that homebuyers will have more options and negotiating power as listings take longer to sell. Berkshire Hathaway Home Services believes there may be a shift in the housing market, offering advice for how buyers and sellers can navigate prices in the midst of continued market swings. Image source: Shutterstock Years of rising mortgage rates have created a housing market stalemate where sellers became hesitant to list their homes, creating a supply shortage and increasing competition among homebuyers. Many first-time homebuyers have been collateral damage, forced to delay or rethink homeownership entirely. Eventually, buyer demand has weakened enough to the point that housing inventory reached a surplus of over 500,000 homes, the highest level since 2013. Now, housing conditions have completely shifted, creating a buyer's market for the first time in years. For sellers to keep their listings competitive, Berkshire Hathaway Home Services suggests they may need to implement price reductions. More on homebuying: The White House will take surprising approach to curb mortgage ratesHousing expert reveals surprising ways to reduce your mortgage rateDave Ramsey predicts major mortgage rate changes are coming soonWarren Buffett's Berkshire Hathaway sounds the alarm on the 2025 housing market The blog recommends that sellers examine home prices in their area and look at home sales trends over the past few months. "Accept the current market. Ask for an updated comparative market analysis with detailed sales trends over the last three months. Are home sales slowing or accelerating? Are home prices rising or falling? Price your home slightly under the trends." found that home listings spent an average of 51 days on the market in May, up from 45 days in May 2024 but on par for the pre-Covid housing market. However, the number of unsold homes is up 21% from last year, marking a considerable change in sales trends. In March, which is typically the onset of renewed buyer demand during the spring housing market, 23% of home listings received a price reduction. Now, as housing inventory rises, sellers are losing the upper hand and may need to lower their pricing expectations. Related: Fannie Mae predicts major mortgage rate changes are coming soon The Berkshire Hathaway Home Services blog wrote that, "A price reduction should send the right message to the marketplace - that your home is well worth its asking price." It also suggests that sellers may need to put in more effort to draw in buyers and close sales. "Pay for professional staging and photography to showcase your home to better advantage online. Highlight the charms and special features of your home as well as the neighborhood." While this may not be the shift sellers were hoping for, a more favorable environment for buyers may be enough to motivate housing activity and undo the current gridlock. Related: Veteran fund manager unveils eye-popping S&P 500 forecast The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
Indianapolis Star
44 minutes ago
- Indianapolis Star
New to The Street Episode #671 Airs Tonight on Bloomberg Television at 6:30 PM EST Featuring FLOKI, Arrive AI (NASDAQ: ARAI), Health In Tech (NASDAQ: HIT), Vita Bella, and NRX Pharmaceuticals (NASDAQ: NRXP)
This week's episode is sponsored by The Sustainable Green Team's Waterless Garden (OTC:SGTM) and PetVivo Holdings, Inc.'s (NASDAQ:PETV) innovative SPRYNG™ product. NEW YORK CITY, NY / ACCESS Newswire / June 14, 2025 / New to The Street, the nationally syndicated business television series known for spotlighting innovation across sectors, announces the premiere of Episode #671 airing tonight on Bloomberg Television at 6:30 PM EST. This week's broadcast features five dynamic companies making waves across blockchain, AI, health tech, wellness, and pharmaceutical sectors: FLOKI – The globally recognized crypto and blockchain brand building Web3 utility through its DeFi ecosystem. Arrive AI (NASDAQ:ARAI) – Developer of a patented smart mailbox delivery platform, leading last-mile logistics innovation with its autonomous, AI-powered systems. Health In Tech (NASDAQ:HIT) – A pioneer in digital underwriting and quote-to-card technology for health insurance, transforming how plans are built and priced. Vita Bella – A wellness brand that continues to expand its national presence through health-focused lifestyle offerings. NRX Pharmaceuticals (NASDAQ:NRXP) – A late-stage pharmaceutical company advancing treatments for CNS disorders and respiratory distress. This week's featured corporate sponsors include: The Sustainable Green Team (OTC:SGTM) and its revolutionary Waterless Garden initiative for drought-resistant, sustainable landscaping. PetVivo Holdings, Inc. (NASDAQ:PETV), showcasing continued progress with its SPRYNG™, a veterinary injectable device for treating osteoarthritis in companion animals. Upcoming Highlights: New to The Street has also wrapped filming this week with several prominent brands: GLINT Pay (Private) – A disruptive gold-as-money platform allowing real-time gold transactions. Lahontan Gold Corp. (TSX.V:LG / OTCQB:LGCXF) – Canadian gold exploration company with high-grade assets in Nevada. Greer Consulting Group – Providing strategic solutions across regulatory compliance, M&A, and executive strategy. Special Feature Segment: A culinary showcase from two of New York City's most iconic dining destinations – Black Barn and Hunt & Fish Club – blending luxury hospitality with the business of restaurant branding. Additionally, special segments fromIMG Academy, Skip Barber Racing School, and KITON will continue to roll out in the coming months as part of New to The Street's ongoing coverage of elite performance, luxury, and innovation. Quote from Vince Caruso, Creator and Executive Producer of New to The Street: 'We continue to be a destination for innovative and publicly traded companies ready to tell their story at scale. Tonight's show blends AI, healthcare, crypto, and wellness with real national TV exposure. We're proud to feature these brands and grateful to our show sponsors for helping amplify their messages.' About New to The Street Since 2009, New to The Street has become one of the most trusted platforms for public and private companies to share their stories. The show combines sponsored programming with earned media, enhanced by iconic outdoor campaigns, nationwide TV commercials, and non-deal roadshows that connect executives with top-tier investors and institutions. With weekly reach across 220 million linear TV households, a growing 2.65 million YouTube subscribers, and a robust social media presence exceeding 700,000 followers across LinkedIn, Facebook, Instagram, and X, New to The Street delivers unparalleled exposure and credibility in the business media space. For more information, visit SOURCE: New To The Street View the original press release on ACCESS Newswire
Yahoo
an hour ago
- Yahoo
OKYO Pharma Limited's (NASDAQ:OKYO) market cap up US$38m last week, benefiting both individual investors who own 58% as well as insiders
OKYO Pharma's significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public 42% of the business is held by the top 12 shareholders Insider ownership in OKYO Pharma is 36% We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. A look at the shareholders of OKYO Pharma Limited (NASDAQ:OKYO) can tell us which group is most powerful. We can see that individual investors own the lion's share in the company with 58% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn). Following a 58% increase in the stock price last week, individual investors profited the most, but insiders who own 36% stock also stood to gain from the increase. Let's take a closer look to see what the different types of shareholders can tell us about OKYO Pharma. View our latest analysis for OKYO Pharma Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index. As you can see, institutional investors have a fair amount of stake in OKYO Pharma. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of OKYO Pharma, (below). Of course, keep in mind that there are other factors to consider, too. We note that hedge funds don't have a meaningful investment in OKYO Pharma. Gabriele Marco Cerrone is currently the largest shareholder, with 29% of shares outstanding. For context, the second largest shareholder holds about 6.8% of the shares outstanding, followed by an ownership of 5.9% by the third-largest shareholder. Our studies suggest that the top 12 shareholders collectively control less than half of the company's shares, meaning that the company's shares are widely disseminated and there is no dominant shareholder. Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There is a little analyst coverage of the stock, but not much. So there is room for it to gain more coverage. While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it. Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group. Our information suggests that insiders maintain a significant holding in OKYO Pharma Limited. Insiders have a US$37m stake in this US$102m business. It is great to see insiders so invested in the business. It might be worth checking if those insiders have been buying recently. The general public, who are usually individual investors, hold a substantial 58% stake in OKYO Pharma, suggesting it is a fairly popular stock. This level of ownership gives investors from the wider public some power to sway key policy decisions such as board composition, executive compensation, and the dividend payout ratio. I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. To that end, you should learn about the 4 warning signs we've spotted with OKYO Pharma (including 2 which make us uncomfortable) . If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
